Cadila gets USFDA Approval for Generic Drug to Treat Parkinson’s Disease
Cadila Healthcare announced on December 14, 2017, that they have received approval from the US Food and Drug Administration (FDA) to manufacture Pramipexole Dihydrochloride extended-release tablets, which is used for treatment of Parkinson’s disease.
Parkinson’s disease is a neurodegenerative disorder, which results in to progressive deterioration of motor function due to loss of dopamine-producing brain cells. It is characterized by symptoms such as dementia, depression, and anxiety. According to Parkinson’s Disease Therapeutic Market report published by Coherent Market Insights, there is no proper cure available for the treatment of Parkinson’s disease currently. Treatments options such as medication and surgery to manage the symptoms are available. However, various formulations of drugs such as Pramipexole Dihydrochloride can be effectively used to treat and lower the symptoms of disease.
Zydus Pharmaceuticals (USA) Inc, Cadila Healthcare’s has now received the FDA approval for Pramipexole Dihydrochloride extended-release tablets for treatment of Parkinson’s disease in the American pharmaceutical market.
Pramipexole Dihydrochloride extended-release tablets is available in strengths of 0.375 mg, 0.75 mg, 1.5 mg, 2.25 mg, 3 mg, 3.75 mg, and 4.5 mg. The group also received the final approval from the USFDA to market Nitrofurantoin Capsules USP (macrocrystals), 50 mg and 100 mg, which is indicated to treat acute uncomplicated urinary tract infections. Both the drugs will be manufactured at the group’s formulations manufacturing facility at Moraiya, Ahmedabad. Shares of Cadila on December 15, 2017 ended 0.34 per cent up at Rs 409.35 on BSE.
Request Sample copy of Parkinson’s Disease Therapeutic Market Report @ https://www.coherentmarketinsights.com/insight/request-sample/494
You may be interested
Smart Nanotechnology Enlivens Wooden Ships and ArtifactsMohit Joshi - January 28, 2019
Scientists developed an innovative approach using ‘smart’ nanocomposites to conserve 16th-century British warship, the Mary Rose, and its artifacts. Shipwrecks are preserved in sediments under cold water,…
Researchers Discovered New Properties of Ferroelectric CrystalMohit Joshi - January 25, 2019
Researchers discovered new properties of ferroelectric crystal, according to a study published on July 10, 2018. This study was conducted by a team of researchers from China.…
Researchers Develop Novel Antibody to Knockdown of Protein in VertebratesMohit Joshi - January 24, 2019
Researchers from Technische Universität Dresden developed a synthetic antibody that improves functional analysis of proteins. A research led by Dr. Jörg Mansfeld of the Biotechnology Center of…